Johnson & Johnson
Trade Johnson & Johnson 24 hours a day, five days a week on Robinhood.
Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.About JNJ
Johnson & Johnson is a holding company, which engages in the research, development, manufacture, and sale of products in the healthcare field. It operates through the Innovative Medicine and MedTech segments.
JNJ Key Statistics
Stock Snapshot
The current Johnson & Johnson(JNJ) stock price is $265.26, with a market capitalization of 639.25B. The stock trades at a price-to-earnings (P/E) ratio of 30.80 and offers a dividend yield of 1.97%.
On 2026-08-28, Johnson & Johnson(JNJ) stock moved within a range of $264.27 to $267.29. With shares now at $265.26, the stock is trading +0.4% above its intraday low and -0.8% below the session's peak.
Trading volume for Johnson & Johnson(JNJ) stock has reached 2.74M, versus its average volume of 6.34M.
Over the past 52 weeks, Johnson & Johnson(JNJ) stock has traded between a high of $276.47 and a low of $173.33.
Over the past 52 weeks, Johnson & Johnson(JNJ) stock has traded between a high of $276.47 and a low of $173.33.
JNJ News
Key Points Johnson & Johnson has increased its dividend for 64 consecutive years. Merck has raised its dividend for 26 consecutive years. Both drug companies...
I've done extensive searches for a dividend stock that investors can actually sleep well owning, and I keep coming back to Johnson & Johnson (JNJ -1.57%). Right...
Johnson & Johnson (JNJ) shares are trading against the backdrop of a fresh U.S. Food and Drug Administration approval for Imaavy, the first and only treatment s...
Analyst ratings
73%
of 26 ratingsMore JNJ News
...
Key Points Imaavy can be used to treat patients aged 12 and older with warm autoimmune hemolytic anemia (wAIHA), a rare blood disease. It's the second FDA win...
Johnson & Johnson (NYSE: JNJ) received FDA approval for IMAAVY as the first treatment for adults with warm autoimmune hemolytic anemia, providing a new option f...
Johnson & Johnson JNJ announced that the FDA has approved Imaavy (nipocalimab-aahu) for the treatment of warm autoimmune hemolytic anemia (wAIHA) in adults and...
Johnson & Johnson Is Near a Record High. Is There Still Room to Run? By Vandita Jadeja Published Aug 25, 12:00PM EDT Quick Read JNJ trades at $270, inches fro...
How to Build $3,100 a Month in Dividend Income Starting From Zero By David Beren Published Aug 24, 3:59PM EDT Quick Read Generating $3,100 a month in dividend...
Key Points Abbott Laboratories has faced challenges, but it should successfully overcome them. Johnson & Johnson is performing well, and there could be more t...
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.